INSIGHTS+ Insights+: Trends in the US FDA Oncology Approvals (2011-2021)BySenior EditorMarch 24, 20220Comments
VIEWPOINTS PharmaShots Interview: Takeda’s Elke Walter & Derek Wallace Share Insights on TAK-003 for Dengue & Zika VirusesBySenior EditorMarch 23, 20220Comments
VIEWPOINTS PharmaShots Interview: Astellas’ John C. Hairston & Gabriel P. Haas Share Insights on Xtandi (enzalutamide) for the Treatment of Prostate CancerBySenior EditorMarch 22, 20220Comments
VIEWPOINTS PharmaShots Interview: Tillotts Pharma’s Adrian Hill & Christian Weidenfeller Share Insights on Dificlir (fidaxomicin) for the Treatment of Clostridioides Difficile InfectionBySenior EditorMarch 21, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in February 2022BySenior EditorMarch 17, 20220Comments
VIEWPOINTS PharmaShots Interview: Clario’s Lynne Borthwick Shares Insight on Winning Top Workplace Award by EnergageBySenior EditorMarch 16, 20220Comments
VIEWPOINTS PharmaShots Interview: Dermavant’s Philip Brown Shares Insight on the P-III (PSOARING 3) Study of TapinarofBySenior EditorMarch 15, 20220Comments
VIEWPOINTS PharmaShots Interview: Jazz Pharmaceuticals’ Bruce C. Cozadd Shares Insight on Vision 2025 During the Virtual Presentation at 40th Annual J.P. Morgan Healthcare Conference 2022BySenior EditorMarch 14, 20220Comments
